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Background: The influenza pandemics have resulted in significant morbidity and mortality worldwide. Animal
models are useful in the study of influenza virus pathogenesis. Because of various limitations in current laboratory
animal models, it is essential to develop new alternative animal models for influenza virus research aimed at
understanding the viral and host factors that contribute to virus infection in human.
Method: We investigated the replicative efficiency of influenza H1N1 virus (classic strain (Influenza A/PR/8/34),
seasonal influenza isolate (A/Guangzhou/GIRD/02/09) and swine-origin human influenza virus (A/Guangzhou/GIRD/
07/09)) at Day1,2,4,6 and 9 p.i. using TCID50 and qPCR assay in tree shrew model. Body temperature was monitored
in the morning and evening for 3 days before infection and for 14 days. Seroconversion was detected by
determining the neutralizing antibody titers against the challenge viruses in the pre- and exposure serum samples
collected before infection and at 14 days p.i., respectively. Lungs and tracheas of tree shews were collected at day
14 post p.i. for histopathological analysis. Lectinhistochemistry analysis was conducted to identify the distribution of
SAα2,3 Gal and SAα2,6 Gal receptors in the lung and trachea.
Results: The infected tree shrew displayed mild or moderate systemic and respiratory symptoms and pathological
changes in respiratory tracts. The human H1N1 influenza virus may replicate in the upper respiratory tract of tree
shrews. Analysis of the receptors distribution in the respiratory tract of tree shrews by lectinhistochemistry showed
that sialic acid (SA)α2,6-Gal receptors were widely distributed in the trachea and nasal mucosa, whereas (SA)α2,3-Gal
receptor was the main receptor in the lung tissue.
Conclusions: Based on these findings, tree shrew seemed to mimic well influenza virus infection in humans. We
propose that tree shrews could be a useful alternative mammalian model to study pathogenesis of influenza H1N1
virus.
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Influenza viruses infecting humans cause a range of ill-
nesses from unapparent infections to pneumonia and se-
vere acute respiratory syndrome [1]. Recently, efforts have
been increased to understand the pathogenesis of the vari-
ous influenza virus infections and to develop new methods* Correspondence: jeffyah@163.com; nanshan@vip.163.com
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reproduction in any medium, provided the orof treatment [2]. Thus, it is essential to have laboratory
animal models that replicate the major features of illness
in humans and provide selective and reproducible results.
This selected animal model needs to mimic human influ-
enza, in terms of similarity of clinical signs, histopatho-
logic changes and virus replication kinetics. A number of
animal models such as mice [3], cotton rats [4], guinea
pigs [5], hamsters [6], ferrets [7], non-human primates,
such as macaques [8] have been developed, but many
gaps, including clinical symptoms and transmission, re-
main in our understanding.
Although various laboratory animals have been used in
influenza virus study, each of them has particular advan-d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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hamsters models are widely used for influenza virus re-
search. However, they do not exhibit some of the clinical
symptoms detected in humans such as nasal exudates,
fever, sneezing, and coughing, and only display hypo-
thermia and weight loss. Additionally mice, unlike other
rodents like guinea pigs, cotton rats and hamsters, cannot
be infected with primary human virus clinical isolates
readily, and thus are in mostly used in the research of
mouse-adapted strains [9]. Therefore, the pathogenesis of
influenza virus could not be studied adequately in rodent
models as generally recognized. It is well-known that fer-
rets and non-human primates (e.g. macaques) are excel-
lent mammalian animal models for studies of influenza
virus pathogenicity and host immunity, and moreover, the
clinical signs of influenza virus infection in ferrets resem-
ble those in humans [10,11]. Although these species pro-
vide useful models for influenza virus pathogenesis
studies, some disadvantages of those such as availability,
cost, husbandry demands and ethical constraints limit the
use of them for such research [12]. Until recently, more
efforts have been focused on development of animal
models in attempt to provide more alternative animal
models for study of influenza virus pathogenesis and
antivirals.
The tree shrews (Tupaiabelangeri, family Tupaiidae) are
now widely classified as a separate taxonomic group of
mammals (Scandentia) that probably diverged from the
primate order (Primates) about 85 million years ago
[12,13]. Consequently, tree shrews are phylogenetically
much more closely related to humans, which make it a
useful animal model for some human viral diseases in
Southeast Asia [14]. Currently, tree shrew models are
mainly used for research into the nervous, digestive and
urinary systems, among others [15,16]. In the 1980s, tree
shrews were already being used for animal models for Ep-
stein–Barr virus [17] and rotavirus[18] infection. The tree
shrew models have also been used widely for infection













A/PR8/34 99.77±0.42 39.78±0.44 Positive (3/3)c 2.94±0.92
GZ/02/09 98.92±0.63 40.26±0.55 Positive (3/3) 3.00±0.33
S-OIV/GZ/07/09 100.24±0.49 40.57±0.59 Positive (3/3) 4.24±0.25
Control 99.46±0.36 38.20±0.47 No 0
a Bodyweight on day o.
b Average body temperature on day 2 p.i.
c Number of inoculated tree shrews/total number.
d Peak nasal wash titers are expressed as the mean±SD log10 TCID50/mL.
e Virus titers in different tissues was detected on day 2 p.i.
f Serum was collected on day 14 p.i., and homologous strains were used with chickhepatitis C virus [22], measles virus [23], adenovirus
[24,25], herpes simplex virus [26], respiratory syncytial
virus [27], human immunodeficiency virus [28], and rota-
virus [18].
Therefore, we hypothesized that clinically apparent in-
fections can arise from infection of influenza viruses in
tree shrew, and tested our hypothesis to evaluate the tree
shrew to be potential in the study of influenza. In the
present study, we established a small alternative model,
the tree shrew, which could be contributed to further
study of human influenza virus infection.
Results
Virus replication in tree shrews and pathological changes
To evaluate virological characteristics in susceptible tree
shrews, 9 tree shrews (3/group) were intranasally chal-
lenged with 105 TCID50 (50% tissue culture infectious
dose) of the H1N1 strains A/PR/8/34, GZ/02/09 and S-
OIV/GZ/07/09, respectively. Control animals were inocu-
lated with an equal volume of uninfected allantoic fluid.
We examined all clinical symptoms during the course of
infection to characterize the disease caused by virus infec-
tion. All tree shrews were observed to be clinically normal
signs on day 0. Clinical signs of infection were initially ob-
served on day 1 post-infection (p.i.), with most animals
exhibiting signs by day 3 or 4 p.i. and gradually dis-
appeared by day 9 p.i. Clinical signs observed in three
infected groups included hypoactivity, and increasing
nasopharyngeal secretion (Table 1). There was no obvious
change in average body weight in animals inoculated with
the viruses compared with the control group (Table 1).We
observed slight fevers in all three strains of influenza vi-
ruses on day 2 and 3 p.i. (Figure 1). However, the result
varied individually. Larger numbers of animals are needed
to be acquired for future studies.
A spectrum of histopathological features was found in
the lungs of tree shrews infected with each influenza
H1N1 virus. Evidence of acute bronchopneumonia and




Number positive/total (average logTCID50/mL)
e Seroconversion
(HI titer)fNasal mucosa Tracheal Lung
(2) (3/3) (1.89) (0/3) (0/3) (3/3) 80,80,320
(2) (3/3) (1.90) (0/3) (0/3) (3/3) 80,160,640
(1) (3/3) (2.17) (0/3) (0/3) (3/3) 80,160,640
(0/3) (0/3) (0/3) (0/3) 0,0,0
en RBCs in HI assay.
Figure 1 Changes in body temperature in tree shrews infected
with H1N1 influenza viruses.
Figure 2 Clinical pathology of infected tree shrew. (A) lung from tree s
inflammatory cell infiltration, hemorrhage, edema, and lung exudate interv
virus with interstitial pneumonia; (C) lung of tree shrew challenged with sw
pneumonia, interstitial edema and hyperemia; (D) control lung tissue; (E) T
virus, with destruction of ciliated epithelia and inflammatory cell infiltration
magnification, and E-F at 400 × magnification.
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Groups of GZ/02/09 and S-OIV/GZ/07/09 showed
evidence of interstitial pneumonia, mild bronchiolitis
(Figures 2B and C). Also, extensive interstitial edema and
hyperemia were characterized in all virus challenge groups
(Figures 2A, B, and C). Moreover, pathological change in
trachea of GZ/02/09 group exhibited infiltration of inflam-
matory cells (Figure 2E). In comparison, the tracheal and
lung tissue from a control tree shrew had no apparent
histological changes (Figure 2D and F).
Nasal washes from the tree shrews were collected on
days 1,2,4,6 and 9 p.i. and subjected to TCID50 and qPCR
assays. The data showed that tested viruses grew to peak
titers on day 1 or day2 p.i., with infectious virus titres ran-
ging from 104.24 to 102.94 TCID50/ml, and dropped to
undetectable levels by day 4 p.i. using TCID50 assay
(Figure 3). This viral growth kinetics was consistent with
that observed from outcome of qPCR assay for each strain
tested (Figure 3). However viral shedding ended by aroundhrew challenged with A/PR8/34 virus with interstitial pneumonia,
al; (B) lung of tree shrew challenged with A/Guangzhou/GIRD/02/09
ine influenza virus A/Guangzhou/GIRD/07/09 with interstitial
rachea from tree shrew challenged with A/Guangzhou/GIRD/02/09
; (F) control trachea tissue. Images A-D were taken at 200×
Figure 3 Influenza virus kinetics of H1N1 influenza viruses infection in tree shrews. Three groups of tree shrews (3/group) were intranasally
inoculated with 105 TICID50 of virus. At indicated time points (days 1,2,4,6 and 9 p.i.), nasal wash samples were collected. Titers (mean±SD) are
presented as logTCID50/mL and log copies.
Yang et al. Virology Journal 2013, 10:111 Page 4 of 9
http://www.virologyj.com/content/10/1/111day 4 to 9 p.i., probably due to superior sensitivity of
qPCR assay. The titer of S-OIV/GZ/07/09 was highest
among all strains tested. Moreover, we detected infectious
virus in homogenate of nasal mucosa with logTCID50/mL
value ranging from 1.89 to 2.17, while no virus was found
in trachea and lung (Table 1). Taken together, upper
respiratory tract of tree shrew may be more permissive
to human clinical isolates when inoculated by intranasal
route.
Furthermore, tree shrews used in the present study
were determined to be seronegative for influenza A vi-
ruses (H1N1), using the hemagglutination inhibition
(HI) test. Some animals in each group after inoculation
with the two viruses possessed recognizable HI antibody
titers range from 80 to 640 Hemagglutinating Units
(HAU) (Table 1).
Distribution of avian and human influenza receptors in
the respiration tracts of tree shrews
We detected the distribution of influenza virus receptors
in a range of tissues from tree shrews. The receptor dis-
tribution was consistent within each individual animal.
Using lectin staining, we found widespread distribution
of both SAα2,6 Gal (Sambucusnigra agglutinin; SNA)
and SAα2,3 Gal(Maackiaamurensislectin II; MAA II)
receptors in the respiratory tract. In the nasal mucosa,
SA α2,6 Gal receptors were widely expressed on the
squamous epithelial cells, vascular endothelial cells and
the epithelial cells of the gland, only a few SAα2,3 Gal
receptor were detected on squamous epithelial cells,
(Figure 4A, B). The SA α2,6 Gal receptor was mostly
detected in the pseudostratified ciliated cells of the tra-
chea, whereas only a few SAα2,3 Gal were found in the
same area (Figure 4D,E). In the mixed glands of the sub-
mucosa layer, both receptors in endothelial cells of blood
vessels were detected (Figure 4D,E). In lung tissue, the
non-ciliated cuboidal epithelium of the terminal bron-chioles mainly expressed SAα2,6 Gal (Figure 4G), whe-
reas alveolar epithelial cells mainly expressed SAα2,3
Gal, and alveolar macrophages also expressed SAα2,3
Gal (Figure 4H). Treatment with neuraminidase prior to
lectin staining resulted in absence of staining and thus
confirmed the specificity for both SNA and MAA II
(Figure 4C,F,I). The distribution of SAα2,6 Gal was
mainly detected in the trachea and bronchus and to a
lesser degree in the alveolar cells. In contrast, SAα2,3Gal
receptor was more regularly observed in respiratory
bronchiolar and lung alveolar cells, and only sporadic
expression of SAα2,3Gal was observed in the tracheal,
bronchial and bronchiolar epithelial cells.
Discussion
We used a tree shrew (TupaiaBelangeri, family Tupaiidae)
model to study clinical signs, virus shedding, pathology of
influenza virus A H1N1 and sialic acid receptor type
distribution. Our results demonstrated that influenza
H1N1 virus replicated efficiently in respiratory tract of
tree shrews, and showed mild or moderate clinical signs
and pathological changes. These findings in tree shrews
seemed in accord with related manifestations in human
influenza infections [1]. It also revealed that upper respira-
tory tract of tree shrew may be more permissive to human
clinical isolates when inoculated by intranasal route. Pat-
terns of influenza virus receptor distribution in the upper
and lower respiratory tract are also similar in tree shrews
and humans [29-32]. Taken together, our results suggested
that tree shrews could be a promising alternative animal
model for the study of influenza pathogenesis.
Main clinical signs in this model include slightly in-
creased body temperature and nasal secretion, but an-
orexia and lethargy were not obvious. Although sneezing
occurred occasionally, it was more frequently associated
with the common cold than with influenza. Tree shrews
usually had fever after inoculation with high challenge
Figure 4 Distribution of avian (SAα2,3) and human (SAα2,6) influenza receptors in the nasal mucosa, trachea and lung of tree shrews.
Both avian influenza virus receptor SAα2,3 Gal binding with MAA II and human influenza virus receptor SA α2,6 Gal binding with SNA are shown
in brown. Stained with SNA (A,D,G), MAA II (B,E,H). SNA and MAA II lectins on sections previously treated with neuraminidase, where no faint
binding was detected (C,F,I). A–C, Nasal mucosa. (A) In the nasal mucosa, stained SNA were detected on squamous epithelial cells (⬆) and
vascular endothelial cells (B) Only a few of MAA staining was visible on squamous epithelial cells. D–F, Trachea (D) SNA staining was visible on
almost all epithelial cells (E) a few stains of SA α2,3 Gal were found (⬆). G–I, lung (G) In the lung, non-ciliated cuboidal epithelium of the terminal
bronchioles mainly expressed SAα2,6 Gal (⬆). (H) In the lung, alveolar epithelial cells mainly expressed SA α2,3 Gal and alveolar macrophages also
expressed SA α2,3 Gal (⬆). Magnification ×400.
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levels by around one week, which was similar to human
infection timeline [1]. Because both of systemic and re-
spiratory symptoms were characteristically observed in
tree shrews infected, indeed the symptomatology found
in tree shrews was partly similar to human influenza in-
fections without complication [1]. Additionally, the dis-
ease manifestations of influenza virus infection in tree
shrews also partly resembled those in an excellent mam-
malian animal model (eg. ferret) [7]. However, loss ap-
petite, congested eyes and otologic manifestation were
not observed in tree shrews, but in ferrets [33,34]. The
mouse model can manifest no obvious clinical signs of
influenza-like illness, but develop severe pneumonia.
Thus far, the tree shrews seem not superior to the ferret
model, but have the advantage over the rodent model in
the clinical similarity. The serological data showed that
tree shrews readily seroconvert in response to intranasal
inoculation of virus, and serum neutralizing antibody
titers of infected animals range from 80 to 640. Con-sidering the clinical symptoms and antibody immune re-
sponse observed in tree shrews, it is reasonable to pre-
sume this model is potential to evaluate the efficacy of
antiviral agents and vaccine for the prevention of influ-
enza infection. However, the tree shrew infected with
human influenza model didn’t result in lethality, thereby
detection of increasing nasal wash titers can serve as
endpoints for determination of vaccine efficacy.
In particular, in our study the tested influenza H1N1 vi-
ruses (including classic strain, seasonal isolate and novel
swine H1N1) could infect the tree shrews without prior
adaptation. Thus, tree shrew model could be one of the
attractive options for the study of pathogenesis and anti-
viral agent shortly once new influenza viruses emerge.
Like humans, tree shrews inoculated with human in-
fluenza viruses demonstrated a primarily upper respira-
tory tract infection. Influenza viruses could be isolated at
high titers from nasal washes, but no virus could be
detected in tracheas and lungs. In addition, the infec-
tions in tree shrew were only induced by the high virus
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Nevertheless, it is likely that the tested human influenza
infections are self-limited in tree shrew model like
humans. Histopathological analysis indicated that clini-
cal isolate influenza H1N1 virus infection caused exu-
dative and interstitial pneumonia, moderate bronchitis,
mild bronchiolitis, interstitial edema and inflammatory
infiltrates, which showed considerable similarities to in-
fluenza virus pneumonia in human [35] and this also
suggested that damage to the ciliated epithelium may be
caused by the inflammatory response.
It is important to note that receptors play a crucial
role in determining the host specificity and tissue tro-
pism of virus [36]. The hemagglutinin of influenza viru-
ses initiates infection by binding sialic acid (SA) that is
bound to glycans through SA α2,3 Gal or SAα2,6 Gal
linkage [37]. Therefore, the lectinhistochemistry data are
important to evaluate the tree shrew as a model for in-
fluenza virus. We established that both human influenza
(SA a2,6-Gal, SNA) and avian (SA a2,3-Gal, MAA II
specific) receptor types were present in tree shrew re-
spiratory tract, with each tissue showing distinctive ana-
tomical distribution of the two receptors. This suggested
that the respiratory tracts may be permissive to viral
entry or infection. In tree shrews, the SA α2,6 Gal recep-
tor that is more frequently associated with human influ-
enza viruses was restricted primarily to the trachea and
some bronchus, whereas the SAα2,3 Gal receptor prefer-
entially bound by avian viruses was more abundantly
present in the pulmonary alveoli and respiratory epithe-
lium, which was similar to humans and ferrets [36,37].
Considering the anatomical receptor distribution in
upper and lower respiratory tract in tree shrew, it is rea-
sonable to hypothesize that the tree shrew can be
infected with human influenza viruses, but also poten-
tially be infected with high pathogenic avian influenza
virus, even resulting in a lethal pneumonia model. How-
ever, this requires further investigation.
Currently, tree shrews are widely used in medical and
biological research, especially in virology. However, tree
shrews, used as experimental animals, need a suitable
source for this study. Many countries now carry out la-
boratory research on tree shrews, such as in the German
Primate Center [38], and tree shrews have also been
bred successfully. In China, Kunming Medical University
has already achieved local standards for experimental
tree shrews, which provides comprehensive quality as-
surance for artificial propagation and experimental stud-
ies of tree shrews [39,40]. In addition, although ferret is
possibly the best model for influenza in humans, the use
of this species for routine research purposes is prohibi-
tively expensive [12,37]. However, compared to ferrets,
tree shrews can be bred more easily and are relatively in-
expensive to maintain for study.In conclusion, our study aimed to determine whether
the tree shrew provides a useful small alternative model
for the study of influenza H1N1 virus infection. The main
advantages of tree shrews as an experimental model are
phylogenetically close to primates [41], susceptible to in-
fluenza without prior adaptation, small size, low expense
and husbandry, which make the model more accessible to
the researchers. Although the tree shrews mimic well the
disease in humans, the absence of severe infection and
possible differences in drug pharmacokinetics in tree
shrews and humans may limit the study of antiviral treat-
ment. Further efforts are needed to determine its patho-
genesis in tree shrew model such as viral replication in the
extra pulmonary organs as well as its application of assess-
ments of antiviral agents and vaccine. To this end, the tree
shrew model will be useful for assessment of circulating
strains that could challenge human public health.
Methods
Viruses and cells
Classic strain A/PR/8/34 was purchased from ATCC
(American Type Culture Collection). A/Guangzhou/GIRD/
02/09 (GZ/02/09) virus was obtained from unadapted
H1N1 human clinical isolate before 2009 influenza pan-
demic. Novel swine influenza virus (A/Guangzhou/GIRD/
07/09 (S-OIV/GZ/07/09), GenBank Accession No. HM014
332.1) was also an unadapted H1N1 human clinical iso-
late. Virus stocks were produced by passage in 10-day-old
embryonated chicken eggs, which was purchased from
Institute of Animal Husbandry, Guangdong Academy
of Agricultural Sciences. Madin–Darby canine kidney
(MDCK) cells (American Type Culture Collection)
were cultured in Dulbecco’s Modified Eagle’s Medium
supplemented with 10% fetal bovine serum. The
TCID50 was determined for MDCK cells after incuba-
tion at 37°C for 3 days [42], and TCID50 values were
calculated using the Reed–Muench method [43]. All
experiments were performed at biosafety level 2. All
personnel were required to use respiratory protection
during working with live viruses or infected animals.
Ethics statement
All animal research was approved by the Guangdong Pro-
vincial Department of Science and Technology (approval
ID, SYXK (YUE) 2008–0093), which complied with the
guidelines of Guangdong Regulation for Administration of
Laboratory Animals (2010), and the guidelines on the wel-
fare of non-human primates were used in research. A-
nimals were allowed free access to food and water and
kept on a 12-h light/dark cycle, received environmental
enrichment and were monitored daily for evidence of
disease and changes in attitude, appetite, or behavior
suggestive of illness. In cases of suffering animals were
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was stopped by humane killing with subsequent post
mortem analysis.Animals
3-month-old male tree shrews weighing 95-105 g were
obtained from the Animal Experimental Centre of
Kunming Medical University. They were seronegative
by HA inhibition assay to influenza A/PR/8/34, A/
Guangzhou/GIRD/02/09 and A/Guangzhou/GIRD/07/09
human H1N1virus isolates.
Viral inoculation of tree shrews and viral titre
quantification
Twenty four tree shrews, that were seronegative for influ-
enza virus were used in the study. Each animal was lightly
anesthetized with a solution of ketamine/xylazine/atro-
pine, formulated to provide doses of 25 mg/kg ketamine,
1.7 mg/kg xylazine and 0.05 mg/kg of atropine to each
animal. To evaluate the ability of different viral strains to
replicate in tree shrews, ~105 TCID50 was administered to
each animal intranasally in each group of six tree shrews;
three control animals were inoculated with an equal vol-
ume of uninfected allantoic fluid. Clinical signs of infec-
tion and bodyweight and temperature were recorded
daily. In order to measure their body temperatures accur-
ately, animals were quiet after 10 min when captured. To
detect viral titer in respiratory tracts, three animals in each
group were euthanized at day 2 p.i.. Samples of nasal mu-
cosa, trachea and all lobes of the lung were collected and
stored at −80°C. The tissues were weighed and subse-
quently homogenized to make a 10% weight by volume
(w/v) suspension for virus titration on MDCK cells using
TCID50 assay. Nasal wash samples containing 0.3 mL PBS
with antibiotic were collected from all tree shrews on days
1, 2, 4, 6 and 9 for viral titer determination using the
TCID50 assay. Also, we performed quantitative PCR
(qPCR) detection of virus in nasal wash samples by use of
an Applied Biosystems Prism 7500 system,as described
[44]. Nasal wash samples were made into aliquots and
placed on dry ice immediately after collection. Samples
were stored at −80°C until use. Representative sections of
the left lung and trachea were collected from each eutha-
nized or deceased animal for viral load detection. Samples
were snap frozen in liquid nitrogen and stored at −80°C
until analysis.
Serological assays
Serum samples obtained from tree shrews before exposure
were assayed in an HI assay with inactivated antigens for
challenge human influenza A viruses. Seroconversion was
detected by determining the neutralizing antibody ti-ters against the challenge viruses in the pre- and post-
exposure serum samples collected before infection and at
14 days p.i., respectively, by means of virus neutralization
in MDCK cells, as described previously [45].
Histopathological analysis
Lungs and tracheas of euthanized tree shrews were
preserved in 10% phosphate-buffered formalin. Tissues
were then processed for paraffin embedding and cut
into 4-μm-thick sections. One section from each tis-
sue sample was subjected to standard hematoxylin
and eosin staining, while another was processed for
lectinhistochemistry.
Lectinhistochemistry
Two tree shrews were used for sample collection for
characterization of sialic acid receptor type. Expression
of SAα2,3 Gal and SAα2,6 Gal receptors in the lung and
trachea was measured using lectinhistochemistry. Before
histochemistry, neuraminidase pretreatment was per-
formed to confirm the specificity of the lectin stains. All
paraffin-embedded consecutive sections of 4-μm thick-
ness from all of these organs, which were four serial sec-
tions, were stained with biotinylated, SA-specific lectins.
Paraffin-embedded tissue sections were deparaffinized
and immersed in 0.3% hydrogen peroxide methanol to
eliminate endogenous peroxidase activity. Then, each
slide of tissue sections was covered with 10 U/μl neur-
aminidase (NEB, Ipswich, MA, USA) for 24 h incubation
at 37°C. Additional negative controls were performed by
using slides incubated with PBS. Biotinylated MAA II,
which is specific for α-2,3-linked SA (a marker for avian
influenza virus receptor), was purchased from Vector
Laboratories (Burlingame, CA, USA), and biotinylated
SNA, specific for binding the α-2,6 linked sialic acid
(a marker for human influenza virus receptor), were pur-
chased from Vector Laboratories. Lectinhistochemistry
was performed as described previously [30]. Briefly, the
formalin-fixed, paraffin-embedded tissue sections were
deparaffinized and 5% bovine serum albumin was used
to block non-specific staining. Sections were pre-soaked
in PBS and blocked using a biotin–streptavidin blocking
kit (Vector Laboratories) according to the manufac-
turer’s instructions. The tissue sections were incubated
with SNA (0.625 μg/ml) and MAA (1.25 μg/ml) in buffer
at 4°C for 1 h. Then, all tissue sections were incubated
in ready-to-use horseradish peroxidase streptavidin
(Vector Laboratories) buffer for 30 min. Biotinylated-
lectin binding was visualized using a DAB substrate
chromogene kit (Maixin, Fuzhou, China), which gives a
brown color, and slides were counterstained with hema-
toxylin. Negative controls were slides incubated with PBS
instead of the lectin.
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